← Back to headlines
Vertex passes key test in quest to treat kidney diseases
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.
10 Mar, 15:03 — 10 Mar, 15:03
Sources
Showing 1 of 1 sources
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.
